ArticleCancer cell international2023

In vitro and in vivo analyses on anti-NSCLC activity of apatinib: rediscovery of a new drug target V600E mutation.

Jiani Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.